We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Device start-up Quanttus gets $3mm in seed funding
07 Mar 2014
Executive Summary
Wearable monitoring device company Quanttus received $3mm in seed money from Khosla Ventures. Quanttus, founded in October 2012 out of technology from the Microsystem Technology Labs at the Massachusetts Institute of Technology, is designing a wrist-worn device which measures and collects clinical-grade heart rate, respiration, and blood pressure data, then applies algorithms to the information collected to provide insights about the wearer’s vital signs. It is intended for use by both healthy individuals wishing to better understand their overall health and learn about potential health risks, as well as by patients with chronic diseases, such as cardiovascular disease or diabetes, to monitor their condition.
Deal Industry
Medical Devices
Medical Devices
Monitoring Equipment & Devices
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?